{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T13:50:58Z","timestamp":1753883458889,"version":"3.41.2"},"reference-count":41,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"11","content-domain":{"domain":["ascopubs.org"],"crossmark-restriction":true},"short-container-title":["JCO Glob Oncol"],"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:sec>\n            <jats:title>PURPOSE<\/jats:title>\n            <jats:p>There is a lack of literature on treating stage III non\u2013oncogene-driven non\u2013small cell lung cancer (NSCLC) with low-dose immunotherapy in combination with chemotherapy for patients who are not candidates for local therapy up front.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>MATERIALS AND METHODS<\/jats:title>\n            <jats:p>We performed an institutional retrospective analysis of patients with stage III non\u2013oncogene-driven NSCLC deemed ineligible for up-front local therapy. The NACT + I\/O group comprised those who received induction chemotherapy in combination with low-dose nivolumab, and the NACT-alone group comprised those who received chemotherapy alone. Propensity score matching was performed based on stage, histology, and respiratory comorbid status. The primary end point was objective response rate (ORR). Secondary end points were conversion rates to local therapy, progression-free survival (PFS), overall survival (OS), and Grade \u22653 adverse events.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS<\/jats:title>\n            <jats:p>\n              Eighty-two patients were equally divided into the NACT + I\/O and NACT-alone groups. The most common histology was squamous cell (60%), followed by adenocarcinoma (34%) and mixed (5%). Majority (85%) had stage IIIB or IIIC disease. The ORR to induction was 73.1% (complete response 1, partial response [PR] 29, stable disease [SD] 10, progressive disease [PD] 1) in the NACT + I\/O group versus 39% (PR-16, SD-13, PD-12) in the NACT-alone group (\n              <jats:italic>P<\/jats:italic>\n              = .002). The NACT + I\/O group had a higher proportion of patients undergoing sequential local therapy (66%\n              <jats:italic>v<\/jats:italic>\n              46.3%,\n              <jats:italic>P<\/jats:italic>\n              = .075), a better median PFS (not reached [NR]\n              <jats:italic>v<\/jats:italic>\n              11 months,\n              <jats:italic>P<\/jats:italic>\n              = .0014), and median OS (NR\n              <jats:italic>v<\/jats:italic>\n              28 months,\n              <jats:italic>P<\/jats:italic>\n              = .22) compared with the NACT-alone group at a median follow-up of 13.5 months. There were no new safety signals identified.\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION<\/jats:title>\n            <jats:p>Adding low-dose immunotherapy to chemotherapy improved ORRs, conversion rates to local therapy, and PFS in patients with stage III non\u2013oncogene-driven NSCLC, who were ineligible for up-front local therapy.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1200\/go-24-00256","type":"journal-article","created":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T20:00:04Z","timestamp":1742846404000},"update-policy":"https:\/\/doi.org\/10.1200\/crossmark","source":"Crossref","is-referenced-by-count":0,"title":["Real-World Outcomes of Induction Chemotherapy With or Without Low-Dose Nivolumab for Stage III Non\u2013Small Cell Lung Cancer Ineligible for Up-Front Local Therapy: A Propensity Score\u2013Matched Analysis"],"prefix":"10.1200","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1787-8245","authenticated-orcid":true,"given":"Praveen Kumar","family":"Marimuthu","sequence":"first","affiliation":[{"name":"Department of Medical Oncology, Christian Medical College, Vellore, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7119-9710","authenticated-orcid":true,"given":"Josh Thomas","family":"Georgy","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Christian Medical College, Vellore, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9096-3577","authenticated-orcid":true,"given":"Deepa Susan Joy","family":"Philip","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Christian Medical College, Vellore, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9503-5182","authenticated-orcid":true,"given":"Ajoy Oommen","family":"John","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Christian Medical College, Vellore, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6821-5900","authenticated-orcid":true,"given":"Anjana","family":"Joel","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Christian Medical College, Vellore, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5957-6771","authenticated-orcid":true,"given":"Divya Bala","family":"Thumaty","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Christian Medical College, Vellore, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raju Titus","family":"Chacko","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Christian Medical College, Vellore, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prashant","family":"Jambunathan","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Christian Medical College, Vellore, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1534-5397","authenticated-orcid":true,"given":"Zachariah","family":"Thomas","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Christian Medical College, Vellore, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kovilapu","family":"Harikrishna","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Christian Medical College, Vellore, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajesh","family":"Isiah","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology\u2014Unit II, Christian Medical College, Vellore, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon Pradeep","family":"Pavamani","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology\u2014Unit II, Christian Medical College, Vellore, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2814-161X","authenticated-orcid":true,"given":"Balukrishna","family":"Sasidharan","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology\u2014Unit II, Christian Medical College, Vellore, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1692-0058","authenticated-orcid":true,"given":"Manu","family":"Mathew","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology\u2014Unit II, Christian Medical College, Vellore, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2626-9097","authenticated-orcid":true,"given":"Thomas","family":"Alex Kodiatte","sequence":"additional","affiliation":[{"name":"Department of Pathology, Christian Medical College, Vellore, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aparna","family":"Irodi","sequence":"additional","affiliation":[{"name":"Department of Radiology, Christian Medical College, Vellore, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6799-065X","authenticated-orcid":true,"given":"Balamugesh","family":"Thangakunam","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine, Christian Medical College, Vellore, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barney T.J.","family":"Isaac","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine, Christian Medical College, Vellore, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richa","family":"Gupta","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Christian Medical College, Vellore, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jansi","family":"Rani","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Christian Medical College, Vellore, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0981-4751","authenticated-orcid":true,"given":"Ashish","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Christian Medical College, Vellore, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"233","reference":[{"key":"e_1_3_8_2_2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834"},{"key":"e_1_3_8_3_2","article-title":"Cancer statistics, 2020: Report from National Cancer Registry Programme, India","author":"Mathur P","unstructured":"Mathur P, Sathishkumar K, Chaturvedi M, et al: Cancer statistics, 2020: Report from National Cancer Registry Programme, India. JCO Glob Oncol 10.1200\/GO.20.00122","journal-title":"JCO Glob Oncol"},{"key":"e_1_3_8_4_2","doi-asserted-by":"publisher","DOI":"10.1093\/oncolo\/oyad125"},{"key":"e_1_3_8_5_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.01308"},{"key":"e_1_3_8_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00630-6"},{"key":"e_1_3_8_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2021.02.004"},{"key":"e_1_3_8_8_2","first-page":"CD002140","article-title":"Concurrent chemoradiotherapy in non-small cell lung cancer","volume":"6","author":"O'Rourke N","year":"2010","unstructured":"O'Rourke N, I Figuls MR, Bernad\u00f3 NF, et al: Concurrent chemoradiotherapy in non-small cell lung cancer. Cochrane Database Syst Rev 6:CD002140, 2010","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_8_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djr325"},{"key":"e_1_3_8_10_2","article-title":"Outcomes in lung cancer: 9-year experience from a Tertiary Cancer Center in India","author":"Murali AN","unstructured":"Murali AN, Radhakrishnan V, Ganesan TS, et al: Outcomes in lung cancer: 9-year experience from a Tertiary Cancer Center in India. J Glob Oncol 10.1200\/JGO.2016.006676","journal-title":"J Glob Oncol"},{"key":"e_1_3_8_11_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02850115"},{"key":"e_1_3_8_12_2","doi-asserted-by":"publisher","DOI":"10.4103\/0019-509X.180810"},{"key":"e_1_3_8_13_2","doi-asserted-by":"publisher","DOI":"10.4103\/ijc.IJC_469_17"},{"key":"e_1_3_8_14_2","doi-asserted-by":"publisher","DOI":"10.18203\/2320-6012.ijrms20195504"},{"key":"e_1_3_8_15_2","doi-asserted-by":"publisher","DOI":"10.4103\/jcrt.JCRT_377_16"},{"key":"e_1_3_8_16_2","doi-asserted-by":"publisher","DOI":"10.17511\/ijmrr.2020.i01.12"},{"key":"e_1_3_8_17_2","doi-asserted-by":"publisher","DOI":"10.4103\/0973-1482.25849"},{"key":"e_1_3_8_18_2","doi-asserted-by":"publisher","DOI":"10.4103\/2278-330X.119893"},{"key":"e_1_3_8_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2022.07.013"},{"key":"e_1_3_8_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2020.07.014"},{"key":"e_1_3_8_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2021.05.005"},{"key":"e_1_3_8_22_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.03136"},{"key":"e_1_3_8_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30498-3"},{"key":"e_1_3_8_24_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.00149"},{"key":"e_1_3_8_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30365-9"},{"key":"e_1_3_8_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2020.06.015"},{"key":"e_1_3_8_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30641-0"},{"key":"e_1_3_8_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2018.02.023"},{"key":"e_1_3_8_29_2","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.3617"},{"key":"e_1_3_8_30_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.26.7609"},{"key":"e_1_3_8_31_2","doi-asserted-by":"publisher","DOI":"10.1136\/esmoopen-2018-000332"},{"key":"e_1_3_8_32_2","article-title":"Effectiveness of immune checkpoint inhibitors in various tumor types treated by low, per-weight, and conventional doses at a Tertiary Care Center in Mumbai","author":"Patel A","unstructured":"Patel A, Hande V, Mr K, et al: Effectiveness of immune checkpoint inhibitors in various tumor types treated by low, per-weight, and conventional doses at a Tertiary Care Center in Mumbai. JCO Glob Oncol 10.1200\/GO.23.00312","journal-title":"JCO Glob Oncol"},{"key":"e_1_3_8_33_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.01015"},{"key":"e_1_3_8_34_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-2842"},{"key":"e_1_3_8_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2021.07.035"},{"key":"e_1_3_8_36_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2024.1897"},{"key":"e_1_3_8_37_2","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.501"},{"key":"e_1_3_8_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2022.12.042"},{"key":"e_1_3_8_39_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1289207"},{"key":"e_1_3_8_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.102246"},{"key":"e_1_3_8_41_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.00627"},{"key":"e_1_3_8_42_2","unstructured":"ClinicalTrials.gov [Internet]: Identifier NCT03391869 nivolumab and ipilimumab with or without local consolidation therapy in treating patients with stage IV non-small cell lung cancer. 2018. https:\/\/clinicaltrials.gov\/study\/NCT03391869"}],"container-title":["JCO Global Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/GO-24-00256","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T20:01:06Z","timestamp":1742846466000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/GO-24-00256"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":41,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["10.1200\/GO-24-00256"],"URL":"https:\/\/doi.org\/10.1200\/go-24-00256","relation":{},"ISSN":["2687-8941"],"issn-type":[{"type":"electronic","value":"2687-8941"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"2024-06-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-08","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-13","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-24","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e2400256"}}